Europe BioSurgery Market Research Report - Segmented By Type, Application, & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Trends & Growth Forecast (2024 to 2029)

Updated On: January, 2024
ID: 2662
Pages: 143

Europe BioSurgery Market Size (2022 to 2027)

The size of the Biosurgery market in the Europe region was worth USD 5.62 billion in 2022. It is estimated to be growing at a CAGR of 8.43%, to reach USD 8.42 billion by 2027.

BioSurgery is an area dedicated to providing aid in surgery by focusing on various technologies to minimize intra- and post-operative complications. Solutions commonly used in biosurgery comprise innovative, biologically based products for surgical conditions that are often difficult or expensive to manage otherwise.

Biosurgery uses biomaterial, therapeutic, and sophisticated device technologies to improve the health of patients in the orthopedic and post-surgery care departments. Most biosurgery products work by facilitating homeostasis and tissue healing in surgery. An example of this is fibrin sealant, which consists of human fibrinogen and thrombin and helps replicate the tissue healing process by facilitating blood clotting and thereby stopping the bleeding.

The major driver of the European Bio Surgery market is the strong focus on research development, which leads to the launch of various new products and various other technological advancements in the field. This, along with the increasing number of surgeries due to changing lifestyles and increasing consumer awareness, serve as boosters for market growth.

The major factor restraining the Bio Surgery market in Europe is the non-acceptance of certain products such as human tissue, which is essential for regenerative purposes, due to ethical concerns in certain parts of the region. This, along with the high costs and the stringent government regulations, acts as restraints for the market.

This research report on the Europe BioSurgery Market has been segmented and sub-segmented into the following categories.

By Type: 

  • Sealants
  • Hemostatic Agents
  • Adhesion Barriers
  • Soft Tissue Attachments
  • Bone Graft Substitutes
  • Staple line Reinforcement Agents

By Application: 

  • Orthopedic
  • General
  • Neurological
  • Cardiovascular
  • Reconstructive
  • Gynecological
  • Urological
  • Thoracic Surgeries

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Promising companies leading the Europe Biosurgery Market profiled in this report are Baxter International, C.R. Bard, Johnson & Johnson, Covidien PLC, Getinge Group, B. Braun Melsungen AG, Cryolife Inc., Stryker Corporation, Hemostasis LLC., and Sanofi Group.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample